Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-30

Clinical Trial Update: Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease [Phase 3]

View source ↗

Summary

Phase 3 trial investigating shorter benznidazole regimens versus standard regimen for Chagas disease; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benznidazole (benznidazole)

Snippet

Sponsor: Laboratorio Elea Phoenix S.A. | Conditions: Chagas Disease | Phase 3 | Status: RECRUITING